Silver Oak Securities Incorporated Invests $292,000 in CVS Health Corporation (NYSE:CVS)

Silver Oak Securities Incorporated acquired a new stake in CVS Health Corporation (NYSE:CVS - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 4,344 shares of the pharmacy operator's stock, valued at approximately $292,000.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. LaFleur & Godfrey LLC raised its holdings in CVS Health by 49.9% during the fourth quarter. LaFleur & Godfrey LLC now owns 4,836 shares of the pharmacy operator's stock worth $217,000 after purchasing an additional 1,610 shares during the last quarter. Principal Securities Inc. increased its position in shares of CVS Health by 3.2% in the fourth quarter. Principal Securities Inc. now owns 27,881 shares of the pharmacy operator's stock valued at $1,252,000 after buying an additional 859 shares in the last quarter. Allworth Financial LP raised its stake in shares of CVS Health by 23.7% during the 4th quarter. Allworth Financial LP now owns 21,795 shares of the pharmacy operator's stock worth $978,000 after buying an additional 4,182 shares during the last quarter. Atria Wealth Solutions Inc. boosted its position in shares of CVS Health by 62.3% in the 4th quarter. Atria Wealth Solutions Inc. now owns 62,160 shares of the pharmacy operator's stock worth $2,790,000 after buying an additional 23,849 shares in the last quarter. Finally, Kestra Investment Management LLC increased its holdings in CVS Health by 25.5% during the 4th quarter. Kestra Investment Management LLC now owns 6,806 shares of the pharmacy operator's stock valued at $306,000 after acquiring an additional 1,384 shares in the last quarter. Hedge funds and other institutional investors own 80.66% of the company's stock.

Insider Buying and Selling at CVS Health

In other news, Director Guy P. Sansone bought 1,570 shares of the firm's stock in a transaction dated Thursday, June 5th. The stock was acquired at an average cost of $63.70 per share, for a total transaction of $100,009.00. Following the completion of the purchase, the director now owns 12,007 shares of the company's stock, valued at $764,845.90. This trade represents a 15.04% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.22% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several analysts have recently commented on the stock. Piper Sandler increased their price target on shares of CVS Health from $72.00 to $74.00 and gave the company an "overweight" rating in a research report on Friday, March 21st. Wells Fargo & Company reissued an "overweight" rating and issued a $84.00 price target (up from $76.00) on shares of CVS Health in a report on Tuesday, May 6th. Truist Financial upped their price objective on CVS Health from $82.00 to $84.00 and gave the company a "buy" rating in a research report on Monday, May 12th. Robert W. Baird boosted their target price on shares of CVS Health from $51.00 to $71.00 and gave the company a "neutral" rating in a research note on Tuesday, April 15th. Finally, UBS Group raised their price target on shares of CVS Health from $67.00 to $71.00 and gave the stock a "neutral" rating in a research note on Friday, May 2nd. Two investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, CVS Health presently has a consensus rating of "Moderate Buy" and a consensus target price of $74.75.

CVS Health Stock Down 0.3%

Shares of NYSE:CVS opened at $66.91 on Friday. CVS Health Corporation has a 1 year low of $43.56 and a 1 year high of $72.51. The stock has a 50-day simple moving average of $64.98 and a 200-day simple moving average of $60.35. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.63 and a current ratio of 0.82. The stock has a market capitalization of $84.64 billion, a P/E ratio of 15.97, a PEG ratio of 0.96 and a beta of 0.56.

CVS Health (NYSE:CVS - Get Free Report) last issued its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, beating analysts' consensus estimates of $1.62 by $0.63. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The business had revenue of $94.59 billion for the quarter, compared to the consensus estimate of $93.07 billion. During the same quarter last year, the firm posted $1.31 EPS. The business's revenue for the quarter was up 7.0% compared to the same quarter last year. Equities analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.